Business · 25/06/1999Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Adverse Experience Reporting for Licensed Biological Products
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on adverse experiences with licensed biological products and general records, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →